Results 181 to 190 of about 8,114 (214)

The half-life of rFVIIIFc is predominantly extended by FcRn expressed in somatic cells, but not in hematopoietic cells.

, 2015
van der Flier Arjan, Zhan Liu, Tan Siyuan, Chen Kai, Douglas Drager, Tongyao Liu, Patarroyo-White Susannah, Haiyan Jiang, Ran David   +8 more
openalex   +2 more sources

Single-cell atlas reveals heterogeneous response to FcRn blockade in anti-AChR antibody-positive generalised myasthenia gravis. [PDF]

Clin Transl Med
Li HN, Liu J, Huang XY, Zhu L, Liu Z, Yang CS, Zhang B, Huang S, Shi FD, Cai Z, Zhang C.   +10 more
europepmc   +1 more source

Passive Immunity Establishment Through Colostral IgG Absorption in Neonatal Ruminants: Foundation for Efficient Ruminant Production. [PDF]

Animals (Basel)
Yang C, Du M, Ahmad AA, Cheng Y, Gebeyew K.   +4 more
europepmc   +1 more source

Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies. [PDF]

Sci Rep
Lee S, Kyung M, Park M, Park S, Lee J, Kim S, Lee S, Jo M, Jung ST, Lee HW.   +9 more
europepmc   +1 more source

Efgartigimod for treating Guillain-Barré syndrome with poor response to intravenous immunoglobulin: a case report. [PDF]

BMC Neurol
Hu BQ, Wu SX, Tong QW, Ye H, Jin PP.
europepmc   +1 more source

Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction. [PDF]

Neurol Neuroimmunol Neuroinflamm
Tarasco MC, Rinaldi E, Frangiamore R, Vanoli F, Berni A, Iacomino N, Canciello A, Andreetta F, Ciusani E, Bonanno S, Maggi L, Baggi F, Mantegazza R, Antozzi C, Cavalcante P.   +14 more
europepmc   +1 more source

Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report. [PDF]

Neurohospitalist
Maqsood H, Fleming J.
europepmc   +1 more source

FCRN MEDIATED MUCOSAL IMMUNITY AND SUBUNIT VACCINE DELIVERY

, 2009
Lilin Ye
openalex   +1 more source

Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia Gravis. [PDF]

CNS Neurosci Ther
Wang Y, Zhu W, Liu Q, Wen X, Xie N, Liu H, Geng Z, Jiang Y, Di L, Wang M, Lu Y, Duo J, Huang Y, Qian Y, Liu Q, Lv C, Da Y.   +16 more
europepmc   +1 more source

Site-specific adaptive nanovesicles for oral insulin delivery. [PDF]

Sci Adv
Xia B, Xu F, Chen J, Shan S, Shen J, Zhang Y, Wang J, Zhou Z, Sun W, Jia Y, Zhang YL, Zhong J, Zhang G, Wan Y, Hu Z, An W, Fan Y, Bottini M, Wang J, Liang XJ.   +19 more
europepmc   +1 more source